Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy

Min, Sang-Won, Cho, Seo-Hyun, Zhou, Yungui, Schroeder, Sebastian, Haroutunian, Vahram, Seeley, William W., Huang, Eric J., Shen, Yong +6 more·2010·Neuron
DOI 10.1016/j.neuron.2010.08.044

Cited by (959)

Items 401–500 of 959

  1. Phytosterols and Dementia
    Shuang Rong, Rui Xu, LI Wen-fang · 2016 · Plant Foods for Human Nutrition
  2. Cdk5 suppression blocks SIRT1 degradation via the ubiquitin-proteasome pathway in Parkinson's disease models
    Qian Zhang, Pei Zhang, Guangjian Qi, Zheng Zhang, Feng He, Zexi Lv, Xiang Peng, Hongwei Cai, Tong-Xia Li, Xue-Min Wang et al. · 2018 · Biochimica et Biophysica Acta (BBA) - General Subjects
  3. Phosphorylation of serine 305 in tau inhibits aggregation
    Kevin H. Strang, Zachary A. Sorrentino, Cara J. Riffe, Kimberly-Marie M. Gorion, N. Vijayaraghavan, Todd Eliot Golde, Benoit I. Giasson · 2018 · Neuroscience Letters
  4. All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration
    Shirel Argueti-Ostrovsky, Leenor Alfahel, Joy Kahn, Adrian Israelson · 2021 · Cells
  5. Deciphering the Function and Regulation of microRNAs in Alzheimer’s Disease and Parkinson’s Disease
    Lifeng Qiu, Wei Zhang, Eng‐King Tan, Li Zeng · 2014 · ACS Chemical Neuroscience
  6. Recent developments with tau-based drug discovery
    Khalid Iqbal, Fei Liu, Cheng‐Xin Gong · 2018 · Expert Opinion on Drug Discovery
  7. The role of microRNA-34 family in Alzheimer’s disease: A potential molecular link between neurodegeneration and metabolic disorders
    Maryam Bazrgar, Pariya Khodabakhsh, Mercedes Prudencio, Fatemeh Mohagheghi, Abolhassan Ahmadiani · 2021 · Pharmacological Research
  8. Circular RNAs: Emblematic Players of Neurogenesis and Neurodegeneration
    Marianna D’Anca, Francesca Romana Buccellato, Chiara Fenoglio, Daniela Galimberti · 2022 · International Journal of Molecular Sciences
  9. miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q
    Nan Xu, Ang-Di Li, Li-Li Ji, Ye Yao, Zhenyu Wang, Lei Tong · 2019 · European Journal of Histochemistry
  10. Natural Compounds for SIRT1‐Mediated Oxidative Stress and Neuroinflammation in Stroke: A Potential Therapeutic Target in the Future
    Chaoyou Fang, Houshi Xu, Ling Yuan, Zhengyang Zhu, Xiaoyu Wang, Yibo Liu, Anke Zhang, Anwen Shao, Meiqing Lou · 2022 · Oxidative Medicine and Cellular Longevity
  11. Alpha-synuclein alters differently gene expression of Sirts, PARPs and other stress response proteins: implications for neurodegenerative disorders
    Joanna Agata Motyl, Przemysław Leonard Wencel, Magdalena Cieślik, Robert Piotr Strosznajder, Joanna Benigna Strosznajder · 2017 · Molecular Neurobiology
  12. Newer Therapeutic Approaches in Treating Alzheimer’s Disease: A Comprehensive Review
    Radhakrishna Reddi Sree, Manjunath Kalyan, Nikhilesh Anand, Sangeetha Mani, Vasavi Rakesh Gorantla, Meena Kishore Sakharkar, Byoung‐Joon Song, Saravana Babu Chidambaram · 2025 · ACS Omega
  13. Research Towards Tau Imaging
    Jordan R. Jensen, Katryna K. Cisek, Kristen E. Funk, Swati B. Naphade, Kelsey N. Schafer, Jeff Kuret · 2011 · Journal of Alzheimer s Disease
  14. Lysosomal Fusion Dysfunction as a Unifying Hypothesis for Alzheimer's Disease Pathology
    Kristen E. Funk, Jeff Kuret · 2012 · International Journal of Alzheimer s Disease
  15. The effects of resveratrol and SIRT1 activation on dystrophic cardiomyopathy
    Atsushi Kuno, Masaya Tanno, Yoshiyuki Horio · 2015 · Annals of the New York Academy of Sciences
  16. Resveratrol Mitigates Hippocampal Tau Acetylation and Cognitive Deficit by Activation SIRT1 in Aged Rats following Anesthesia and Surgery
    Jing Yan, Ailin Luo, Rao Sun, Xiaole Tang, Yilin Zhao, Jie Zhang, Biyun Zhou, Hua Zheng, Honghui Yu, Shiyong Li · 2020 · Oxidative Medicine and Cellular Longevity
  17. Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications
    Rita Azevedo, Chloé Jacquemin, Nicolas Villain, François Fenaille, Foudil Lamari, François Bécher · 2022 · Cells
  18. Activation of p53 in Down Syndrome and in the Ts65Dn mouse brain is associated with a pro-apoptotic phenotype
    Tramutola, Antonella, Pupo, Gilda, Di Domenico, Fabio, Barone, Eugenio, Arena, Andrea, Lanzillotta, Chiara, Broekaart, Diede, Blarzino, Carla, Head, Elizabeth, Butterfield, D. Allan et al. · 2016 · Journal of Alzheimer s Disease
  19. Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly
    Erin E. Congdon, Yixiang Jiang, Einar M. Sigurdsson · 2021 · Seminars in Cell and Developmental Biology
  20. Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
    Cyrus Jalili, Amir Kiani, Mohammadreza Gholami, Fariborz Bahrehmand, Sajad Fakhri, Somayeh Kakehbaraei, Seyran Kakebaraei · 2023 · IET Nanobiotechnology
  21. Recent Aspects of Periodontitis and Alzheimer’s Disease—A Narrative Review
    Dominika Cichońska, Magda Mazuś, Aida Kusiak · 2024 · International Journal of Molecular Sciences
  22. Invited review: Drug development for tauopathies
    Fiona Grüninger · 2014 · Neuropathology and Applied Neurobiology
  23. Sirtuins as modifiers of Parkinson's disease pathology
    Bor Luen Tang · 2016 · Journal of Neuroscience Research
  24. Role of Tau Acetylation in Alzheimer’s Disease and Chronic Traumatic Encephalopathy: The Way Forward for Successful Treatment
    Lucke Wold B · 2017 · Journal of Neurology and Neurosurgery
  25. Targeting Sirtuin 1 signaling pathway by ginsenosides
    Tingting Lou, Qingxia Huang, Hang Su, Daqing Zhao, Xiangyan Li · 2020 · Journal of Ethnopharmacology
  26. The Role of Tau Proteoforms in Health and Disease
    Zuha Waheed, Jawaria Choudhary, Faria Hasan Jatala, Fatimah, Aneeqa Noor, Inga Zerr, Saima Zafar · 2023 · Molecular Neurobiology
  27. The citrus flavonoid “Nobiletin” impedes STZ-induced Alzheimer’s disease in a mouse model through regulating autophagy mastered by SIRT1/FoxO3a mechanism
    Shohda A. El‐Maraghy, Aya Reda, Reham M. Essam, Mona A. Kortam · 2023 · Inflammopharmacology
  28. Blocking SIRT1 inhibits cell proliferation and promotes aging through the PI3K/AKT pathway
    Hongyan Li, Rong Wang · 2017 · Life Sciences
  29. The propagation mechanisms of extracellular tau in Alzheimer’s disease
    Yun Wei, Meixia Liu, Dong‐Xin Wang · 2021 · Journal of Neurology
  30. The path to epigenetic treatment of memory disorders
    Mikael Allan Mikaelsson, Courtney A. Miller · 2011 · Neurobiology of Learning and Memory
  31. Emerging Diagnostic and Therapeutic Strategies for Tauopathies
    David G. Coughlin, David John Irwin · 2017 · Current Neurology and Neuroscience Reports
  32. Nutrient-Dependent Changes of Protein Palmitoylation: Impact on Nuclear Enzymes and Regulation of Gene Expression
    Matteo Spinelli, Salvatore Fusco, Claudio Grassi · 2018 · International Journal of Molecular Sciences
  33. Biomolecular condensation of the microtubule-associated protein tau
    Tina Ukmar, Susanne Wegmann, Markus Zweckstetter · 2019 · Seminars in Cell and Developmental Biology
  34. Circadian Rhythm Disruption and Alzheimer's Disease: The Dynamics of a Vicious Cycle
    Ashish Sharma, Gautam Sethi, Murtaza M. Tambuwala, Alaa A. A. Aljabali, Dinesh Kumar Chellappan, Kamal Dua, Rohit Goyal · 2020 · Current Neuropharmacology
  35. Sirtuin 3 (SIRT3) Pathways in Age-Related Cardiovascular and Neurodegenerative Diseases
    Ciprian Nicolae Silaghi, Marius Florin Farcas, Alexandra Marioara Craciun · 2021 · Biomedicines
  36. The Effects of SIRT1 on Alzheimer's Disease Models
    Gizem Dönmez · 2012 · International Journal of Alzheimer s Disease
  37. α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies
    Francisco Javier Padilla-Godínez, Eunice Ruth Vázquez-García, María Isabel Trujillo-Villagrán, Luis Oskar Soto-Rojas, Marcela Palomero‐Rivero, Omar Hernández-González, Francisco Pérez-Eugenio, Omar Collazo-Navarrete, Óscar Arias-Carrión, Magdalena Guerra‐Crespo · 2025 · Frontiers in Neuroscience
  38. Epigenetics of Alzheimer's Disease and Frontotemporal Dementia
    Chendhore S. Veerappan, Sama F. Sleiman, Giovanni Coppola · 2013 · Neurotherapeutics
  39. Epigenetic drugs in Alzheimer’s disease
    Mar Cuadrado‐Tejedor, Julen Oyarzábal, María Pascual‐Lucas, Rafael Franco, Ana García‐Osta · 2013 · BioMolecular Concepts
  40. Post-translational modifications in neurodegeneration
    Alessandro Didonna, Federico Benetti · 2015 · AIMS Biophysics
  41. Neuroepigenetics of Aging and Age-Related Neurodegenerative Disorders
    Roy Lardenoije, Ehsan Pishva, Katie Lunnon, Daniël van den Hove · 2018 · Progress in molecular biology and translational science
  42. Emerging Role of microRNAs in Dementia
    Sarayu Ramakrishna, Ravi Sondekoppa Muddashetty · 2019 · Journal of Molecular Biology
  43. Frontrunner in Translation: Progressive Supranuclear Palsy
    Ali Shoeibi, Nahid Olfati, Irene Litvan · 2019 · Frontiers in Neurology
  44. The Two Cysteines of Tau Protein Are Functionally Distinct and Contribute Differentially to Its Pathogenicityin Vivo
    Engie Prifti, Eleni N. Tsakiri, Ergina Vourkou, George M. Stamatakis, Martina K. Samiotaki, Katerina Papanikolopoulou · 2020 · Journal of Neuroscience
  45. Neural stem cell-derived exosomes promote mitochondrial biogenesis and restore abnormal protein distribution in a mouse model of Alzheimer's disease
    Bo Li, Yujie Chen, Yan Zhou, Xuanran Feng, Guojun Gu, Shuang Han, Nianhao Cheng, Yawen Sun, Yiming Zhang, Jiahui Cheng et al. · 2023 · Neural Regeneration Research
  46. Tau‐targeting nanoparticles for treatment of Alzheimer's disease
    Shreya Pawar, Mohd Ahmar Rauf, Hosam Gharib Abdelhady, Arun K. Iyer · 2024 · Exploration
  47. Pseudo-acetylation of multiple sites on human Tau proteins alters Tau phosphorylation and microtubule binding, and ameliorates amyloid beta toxicity
    Marianna Karina Gorsky, Sylvie Burnouf, Oyinkan Sofola-Adesakin, Jacqueline Dols, Hrvoje Augustin, Carina Marianne Weigelt, Sebastian Grönke, Linda Partridge · 2017 · Scientific Reports
  48. Chaperone-mediated autophagy: Advances from bench to bedside
    Wenming Li, Tiejian Nie, Haidong Xu, Jing Hui Yang, Qian Yang, Zixu Mao · 2018 · Neurobiology of Disease
  49. Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease
    Hasan A. M. M. Almansoub, Hui Ru Tang, Ying Wu, Ding‐Qi Wang, Yacoubou Abdoul Razak Mahaman, Na Wei, Yusra A. M. Almansob, Wei He, Dan Liu · 2018 · Journal of Alzheimer s Disease
  50. HDAC6 Modulates Signaling Pathways Relevant to Synaptic Biology and Neuronal Differentiation in Human Stem Cell-Derived Neurons
    Jonathan Iaconelli, Lucius L. Xuan, Rakesh Karmacharya · 2019 · International Journal of Molecular Sciences
  51. Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target
    Jianlan Gu, Fei Liu · 2020 · Current Medical Science
  52. Alzheimer’s Disease and other Tauopathies: Exploring Efficacy of Medicinal Plant-derived Compounds in Alleviating Tau-mediated Neurodegeneration
    Siva Sundara Kumar Durairajan, Karthikeyan Selvarasu, Minu Rani Bera, Kaushik Rajaram, Ashok Iyaswamy, Min Li · 2021 · Current Molecular Pharmacology
  53. Deciphering therapeutic options for neurodegenerative diseases: insights from SIRT1
    Ruike Wang, Yingying Wu, Rundong Liu, Mengchen Liu, Qiong Li, Yue Ba, Hui Huang · 2022 · Journal of Molecular Medicine
  54. Age-dependent aggregation of ribosomal RNA-binding proteins links deterioration in chromatin stability with challenges to proteostasis
    Julie Paxman, Zhen Zhou, Richard O’Laughlin, Yuting Liu, Yang Li, Wanying Tian, Hetian Su, Yanfei Jiang, Shayna E Holness, Elizabeth Stasiowski et al. · 2022 · eLife
  55. Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation
    Diana M. Acosta, Chiara D. Mancinelli, Clay Bracken, David Eliezer · 2021 · Journal of Biological Chemistry
  56. The NAD+synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target
    Lu-Zhe Pan, Dae‐Gyun Ahn, Tanveer Sharif, Derek R. Clements, Shashi Ashok Gujar, Patrick W.K. Lee · 2014 · Cell Cycle
  57. The amyloidogenicity of a C-terminal region of TDP-43 implicated in Amyotrophic Lateral Sclerosis can be affected by anions, acetylation and homodimerization
    Archana Prasad, Vishwanath Sivalingam, Vidhya Bharathi, Amandeep Girdhar, Basant Kumar Patel · 2018 · Biochimie
  58. NMR Meets Tau: Insights into Its Function and Pathology
    Guy M. Lippens, Isabelle Landrieu, Caroline Smet‐Nocca, Isabelle Huvent, Neha S. Gandhi, Benoı̂t Gigant, Clément Despres, Haoling Qi, Juan M. Lopez · 2016 · Biomolecules
  59. Potential benefits of medium chain fatty acids in aging and neurodegenerative disease
    E. Dunn, Biqin Zhang, Virender K. Sahota, Hrvoje Augustin · 2023 · Frontiers in Aging Neuroscience
  60. Beyond Amyloid
    Rachel F. Lane, Diana W. Shineman, John Steele, Linda H Lee, Howard M. Fillit · 2012 · Advances in pharmacology
  61. Human apolipoprotein E4 modulates the expression of Pin1, Sirtuin 1, and Presenilin 1 in brain regions of targeted replacement apoE mice
    Francesca Lattanzio, Lucia Carboni, Donatella Carretta, Roberto Rimondini, Sanzio Candeletti, Patrizia Romualdi · 2013 · Neuroscience
  62. Sirt1-deficiency causes defective protein quality control
    Takuya Tomita, Jun Hamazaki, Shoshiro Hirayama, Michael W. McBurney, Hideki Yashiroda, Shigeo Murata · 2015 · Scientific Reports
  63. Tau; One Protein, So Many Diseases
    Tabeshmehr, Parisa, Eftekharpour, Eftekhar · 2023 · Biology
  64. A Potential Role for Sirtuin-1 in Alzheimer’s Disease: Reviewing the Biological and Environmental Evidence
    Mehrane Mehramiz, Tenielle Porter, Eleanor K. O’Brien, Stephanie Ruth Rainey‐Smith, Simon Matthew Laws · 2023 · Journal of Alzheimer s Disease Reports
  65. Tau K321/K353 pseudoacetylation within KXGS motifs regulates tau–microtubule interactions and inhibits aggregation
    Yuxing Xia, Brach M. Bell, Benoit I. Giasson · 2021 · Scientific Reports
  66. Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathies
    Elena Vacchi, Edoardo Lazzarini, Sandra Pinton, Giacomo Chiaro, Giulio Disanto, Francesco Marchi, Thomas Robert, Claudio Staedler, Salvatore Galati, Claudio Gobbi et al. · 2022 · Brain
  67. Potential of chromatin modifying compounds for the treatment of Alzheimer's disease
    Tom C. Karagiannis, Katherine Ververis · 2012 · Pathobiology of Aging & Age-related Diseases
  68. Circadian rhythms and memory formation: regulation by chromatin remodeling
    Saurabh Sahar, Paolo Sassone‐Corsi · 2012 · Frontiers in Molecular Neuroscience
  69. Sirtuin Deacetylases as Therapeutic Targets in the Nervous System
    Brett C. Langley, Anthony A. Sauve · 2013 · Neurotherapeutics
  70. Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington’s Disease
    Marta Fernández‐Nogales, José J. Lucas · 2020 · Frontiers in Cellular Neuroscience
  71. Alzheimer’s Amyloid-β Accelerates Cell Senescence and Suppresses SIRT1 in Human Neural Stem Cells
    Rongyao Li, Yi Li, Haowei Zuo, Gang Pei, Shichao Huang, Yujun Hou · 2024 · Biomolecules
  72. Treatment with the neurotoxic Aβ (25–35) peptide modulates the expression of neuroprotective factors Pin1, Sirtuin 1, and brain-derived neurotrophic factor in SH-SY5Y human neuroblastoma cells
    Francesca Lattanzio, Lucia Carboni, Donatella Carretta, Sanzio Candeletti, Patrizia Romualdi · 2016 · Experimental and Toxicologic Pathology
  73. Tau Filaments and the Development of Positron Emission Tomography Tracers
    Michel Goedert, Yoshiki Yamaguchi, Sushil K. Mishra, Makoto Higuchi, Naruhiko Sahara · 2018 · Frontiers in Neurology
  74. Piperlongumine activates Sirtuin1 and improves cognitive function in a murine model of Alzheimer’s disease
    Jun Go, Thi Kim Quy Ha, Ji Yeon Seo, Tae‐Shin Park, Young‐Kyoung Ryu, Hye‐Yeon Park, Jung‐Ran Noh, Yong‐Hoon Kim, Jung Hwan Hwang, Dong‐Hee Choi et al. · 2018 · Journal of Functional Foods
  75. Schisanhenol improves learning and memory in scopolamine-treated mice by reducing acetylcholinesterase activity and attenuating oxidative damage through SIRT1-PGC-1α-Tau signaling pathway
    Yunfeng Han, Hongyan Yang, Libo Li, Xiaohui Du, Chao Sun · 2018 · International Journal of Neuroscience
  76. AMPK Ameliorates Tau Acetylation and Memory Impairment Through Sirt1
    Lin Wang, Fang-Xiao Shi, Na Li, Yun Cao, Ying Lei, Jian‐Zhi Wang, Qing Tian, Xinwen Zhou · 2020 · Molecular Neurobiology
  77. Role of Sirtuins in Physiology and Diseases of the Central Nervous System
    Justyna Chojdak-Łukasiewicz, Anna Bizoń, Marta Waliszewska‐Prosół, Agnieszka Piwowar, Sławomir P Budrewicz, Anna Pokryszko‐Dragan · 2022 · Biomedicines
  78. Trends and challenges of AAV-delivered gene editing therapeutics for CNS disorders: Implications for neurodegenerative disease
    Boris Kantor, Bernadette O’Donovan, Ornit Chiba‐Falek · 2025 · Molecular Therapy — Nucleic Acids
  79. A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation
    Deepa Ajit, Hanna Trzeciakiewicz, Jui‐Heng Tseng, Connor M. Wander, Youjun Chen, Aditi Ajit, Diamond P. King, Todd J. Cohen · 2019 · Journal of Biological Chemistry
  80. SIRT2 as a potential new therapeutic target for Alzheimer’s disease
    Noemí Sola-Sevilla, Elena Puerta · 2023 · Neural Regeneration Research
  81. Phosphorylation of Tau Protein Associated as a Protective Mechanism in the Presence of Toxic, C-Terminally Truncated Tau in Alzheimer's Disease
    José Luna‐Muñoz, R. Charles, Claude M., Paola Flores-Rodríguez, Jesús Ávila, Rubin Sergio, Fidel de la Cruz, Raúl Mena, Marco Antonio Meraz‐Ríos, Benjamí­n Florán · 2013 · InTech eBooks
  82. SIRT1 Regulation Modulates Stroke Outcome
    Valérie Petegnief, Anna Maria Planas · 2013 · Translational Stroke Research
  83. SIRTain regulators of premature senescence and accelerated aging
    Shrestha Ghosh, Zhongjun Zhou · 2015 · Protein & Cell
  84. Transcellular Spreading of Tau in Tauopathies
    Koen C. Demaegd, Joost W. H. Schymkowitz, Frédéric Rousseau · 2018 · ChemBioChem
  85. Effect and mechanism of fuzhisan and donepezil on the sirtuin 1 pathway and amyloid precursor protein metabolism in PC12 cells
    GUO, PENG, WANG, DESHENG, WANG, XIAOMIN, FENG, HONGLIN, TANG, YING, SUN, RUIHONG, ZHENG, YAN, DONG, LIN, ZHAO, JIAYING, ZHANG, XIN et al. · 2016 · Molecular Medicine Reports
  86. Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies
    Jie Yang, Naiting Shen, Jianying Shen, Ying Yang, Hong-Lian Li · 2023 · Molecular Neurobiology
  87. Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology
    Subha Kalyaanamoorthy, Stanley K. A. Opare, Xiaoxiao Xu, Aravindhan Ganesan, Praveen P. N. Rao · 2024 · Current Alzheimer Research
  88. Effects of Intrinsic and Extrinsic Factors on Aggregation of Physiologically Important Intrinsically Disordered Proteins
    Leonid Breydo, Jennifer Redington, Vladimir Nikolaevich Uversky · 2016 · International review of cytology
  89. Structure-Based Drug Designing Recommends HDAC6 Inhibitors To Attenuate Microtubule-Associated Tau-Pathogenesis
    Amir Zeb, Chanin Park, Shailima DV Rampogu, Minky Son, Gihwan Lee, Keun Woo Lee · 2018 · ACS Chemical Neuroscience
  90. Based on molecular structures: Amyloid-β generation, clearance, toxicity and therapeutic strategies
    Hai Yang, Jin‐Ping Li, Xiaoxiong Li, Linqiu Ma, Mingliang Hou, Huadong Zhou, Rui Zhou · 2022 · Frontiers in Molecular Neuroscience
  91. Targeting Autophagy, Apoptosis, and Oxidative Perturbations with Dapagliflozin Mitigates Cadmium-Induced Cognitive Dysfunction in Rats
    Hany H. Arab, Ahmed H. Eid, Shuruq E. Alsufyani, Ahmed M. Ashour, Azza A. K. El‐Sheikh, Hany W. Darwish, Fatma Mahmoud Sabry · 2023 · Biomedicines
  92. Tau-Targeted Therapeutic Strategies: Mechanistic Targets, Clinical Pipelines, and Analysis of Failures
    Xiaoxia Shen, Huan Li, Beiyu Zhang, Yunan Li, Zheying Zhu · 2025 · Cells
  93. AMPK activation—protean potential for boosting healthspan
    Mark Frederick McCarty · 2013 · AGE
  94. Mental, emotional, and behavioral effects of ketogenic diet for non-epileptic neuropsychiatric conditions
    Ruth Bartelli Grigolon, Fernando Gerchman, Alice Carvalhal Schöffel, Emily R. Hawken, Hartej Gill, Gustavo Héctor Vázquez, Rodrigo Barbachan Mansur, Roger S. McIntyre, Elisa Macedo Brietzke · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  95. Protein lysine acetylation and its role in different human pathologies: a proteomic approach
    Orlando Morales-Tarré, Ramiro Alonso-Bastida, Bolívar Arcos-Encarnación, Leonor Pérez‐Martínez, Sergio Encarnación‐Guevara · 2021 · Expert Review of Proteomics
  96. Sirtuins promote brain homeostasis, preventing Alzheimer’s disease through targeting neuroinflammation
    Mateusz Wątroba, Dariusz Szukiewicz · 2022 · Frontiers in Physiology
  97. Phosphorylation in two discrete tau domains regulates a stepwise process leading to postsynaptic dysfunction
    Peter J. Teravskis, Breeta R. Oxnard, Eric C. Miller, Lisa J. Kemper, Karen H. Ashe, Dezhi Liao · 2019 · The Journal of Physiology
  98. Tau liquid–liquid phase separation: At the crossroads of tau physiology and tauopathy
    Islam, Majedul, Shen, Fengyun, Regmi, Deepika, Petersen, Katherine, Karim, Md Raza Ul, Du, Deguo · 2024 · Journal of Cellular Physiology
  99. Systemic Administration of Neurotransmitter‐Derived Lipidoids‐PROTACs‐DNA Nanocomplex Promotes Tau Clearance and Cognitive Recovery for Alzheimer's Disease Therapy
    Baofeng Gong, Weicong Zhang, Wei Cong, Yuankai Gu, Wenbo Ji, Tong Yin, Honglei Zhou, Honggang Hu, Jianhua Zhuang, Yi Luo et al. · 2024 · Advanced Healthcare Materials
  100. Protein aggregate formation in oligodendrocytes: tau and the cytoskeleton at the intersection of neuroprotection and neurodegeneration
    Christiane Richter‐Landsberg · 2015 · Biological Chemistry